全文获取类型
收费全文 | 917862篇 |
免费 | 65140篇 |
国内免费 | 2397篇 |
专业分类
耳鼻咽喉 | 12770篇 |
儿科学 | 29233篇 |
妇产科学 | 26570篇 |
基础医学 | 129329篇 |
口腔科学 | 25084篇 |
临床医学 | 76563篇 |
内科学 | 187730篇 |
皮肤病学 | 19213篇 |
神经病学 | 73085篇 |
特种医学 | 37016篇 |
外国民族医学 | 336篇 |
外科学 | 145213篇 |
综合类 | 19320篇 |
一般理论 | 263篇 |
预防医学 | 66019篇 |
眼科学 | 20630篇 |
药学 | 64879篇 |
中国医学 | 1833篇 |
肿瘤学 | 50313篇 |
出版年
2018年 | 9727篇 |
2017年 | 7605篇 |
2016年 | 8127篇 |
2015年 | 9268篇 |
2014年 | 13091篇 |
2013年 | 20162篇 |
2012年 | 27013篇 |
2011年 | 28646篇 |
2010年 | 17312篇 |
2009年 | 16418篇 |
2008年 | 27271篇 |
2007年 | 28852篇 |
2006年 | 29030篇 |
2005年 | 28474篇 |
2004年 | 27229篇 |
2003年 | 26311篇 |
2002年 | 25883篇 |
2001年 | 41484篇 |
2000年 | 42666篇 |
1999年 | 36408篇 |
1998年 | 10134篇 |
1997年 | 9299篇 |
1996年 | 9202篇 |
1995年 | 8551篇 |
1994年 | 8192篇 |
1993年 | 7681篇 |
1992年 | 28297篇 |
1991年 | 27067篇 |
1990年 | 26506篇 |
1989年 | 25426篇 |
1988年 | 23647篇 |
1987年 | 23276篇 |
1986年 | 22320篇 |
1985年 | 21249篇 |
1984年 | 15900篇 |
1983年 | 13572篇 |
1982年 | 8211篇 |
1981年 | 7165篇 |
1979年 | 14657篇 |
1978年 | 10291篇 |
1977年 | 8703篇 |
1976年 | 8229篇 |
1975年 | 9017篇 |
1974年 | 10762篇 |
1973年 | 10237篇 |
1972年 | 9713篇 |
1971年 | 8949篇 |
1970年 | 8620篇 |
1969年 | 8057篇 |
1968年 | 7719篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
81.
82.
83.
T.F.A. Lees L. Bogdashich D. Godden 《The British journal of oral & maxillofacial surgery》2021,59(1):e9-e12
Fibroepithelial polyps (FEPs) are common, benign intraoral lesions that tend to develop slowly at predictable sites, often in response to local irritation or trauma. Historical precedent often results in referral to oral and maxillofacial surgery (OMFS) departments for biopsy, often irrespective of symptoms, and histological assessment. OMFS and pathology services are struggling to cope with an increasing workload that will potentially lead to widespread delays to diagnosis and treatment. Over the past 20 years, clinical pathways and guidance have been developed to ensure that healthcare interventions, such as the removal of third molars, tonsils, skin tags, and benign moles, are evidence-based, have a net patient benefit, and ensure the best use of finite NHS resources. However, no such guidance exists for intraoral lesions and we regard this as an oversight. We analysed the removal of 682 FEPs over a seven-year period and report sensitivities of 92.4% for a “confirmed clinical suspicion of an FEP” and 99.7% for a “confirmed clinical suspicion of a benign diagnosis”. The incidence of non-benign disease was 0.3%. Primary care dentists should be able to diagnose and monitor FEPs and refer only if symptoms are serious or in high-risk patients or sites. Adopting this practice across the UK could free up to 1825 four-hour OMFS clinics, 405 hours of consultant histopathologists’ time, and recurring savings to the NHS estimated to be in the region of £620 000/annum. We believe that the removal of FEPs should be reclassified as an “intervention not normally funded”, and the time and resources put to better use treating patients with lesions of questionable pathology. 相似文献
84.
Yang Chih-Hsiang Wang Shirlene Wang Wei-Lin Belcher Britni R. Dunton Genevieve F. 《Journal of behavioral medicine》2022,45(5):702-715
Journal of Behavioral Medicine - Understanding associations between mothers’ and children’s physical activity and sedentary behavior on more fine-grained timescales can provide insights... 相似文献
85.
86.
In both adults and children with diabetes, technologies such as continuous subcutaneous insulin infusion using insulin pumps and continuous glucose monitoring can help improve diabetes control, reduce hypoglycaemia and improve quality of life. Access to these technologies in the UK is very variable. Some technologies are recommended by the National Institute for Health and Care Excellence, while others have not been appraised, and new technologies are emerging all the time. Additionally, different guidelines for adults and children further complicate access to diabetes technology in the transition from paediatric to adult care. Against this background, Diabetes UK and NHS England have brought together a multidisciplinary group of experts, including clinicians and people with diabetes, to develop this consensus guideline, combining the different technologies into a common pathway to aid clinical and policy decision‐making. We created a pathway that supports the incremental addition of technology as monotherapy and then dual therapy in the same way that we incrementally add in therapeutic agents to support people with Type 2 diabetes to achieve their personalized glycaemic targets. The pathway emphasizes the importance of structured education, specialist support and appropriate access to psychological therapies, as essential pillars for optimized use of diabetes‐related technology, and recommends the re‐evaluation of its use when the individual is unable either to use the technology appropriately or to achieve the intended outcomes. This pathway is endorsed by UK‐wide clinical and patient associations and we recommend that providers and commissioners use it to ensure the right individual with diabetes has access to the right technology in a timely way to help achieve better outcomes. 相似文献
87.
Alexander Real Chierika Ukogu Divya Krishnamoorthy Nicole Zubizarreta Samuel K. Cho Andrew C. Hecht James C. Iatridis 《The spine journal》2019,19(2):225-231
Background Context
Low back pain (LBP) is a common complaint in clinical practice of multifactorial origin. Although obesity has been thought to contribute to LBP primarily by altering the distribution of mechanical loads on the spine, the additional contribution of obesity-related conditions such as diabetes mellitus (DM) to LBP has not been thoroughly examined.Purpose
To determine if there is a relationship between DM and LBP that is independent of body mass index (BMI) in a large cohort of adult survey participants.Study Design
Retrospective analysis of prospectively collected National Health and Nutrition Examination Survey (NHANES) data to characterize associations between LBP, DM, and BMI in adults subdivided into 6 subpopulations: normal weight (BMI 18.5–25), overweight (BMI 25–30), and obese (BMI >30) diabetics and nondiabetics. Diabetes was defined with glycohemoglobin A1c (HbA1c) ≥6.5%.Patient Sample
11,756 participants from NHANES cohort.Outcome Measures
Percentage of LBP reported.Methods
LBP reported in the 1999-2004 miscellaneous pain NHANES questionnaire was the dependent variable examined. Covariates included HbA1c, BMI, age, and family income ratio to poverty as continuous variables as well as race, gender, and smoking as binary variables. Individuals were further subdivided by weight class and diabetes status. Regression and graphical analyses were performed on the study population as a whole and also on subpopulations.Results
Increasing HbA1c did not increase the odds of reporting LBP in the full cohort. However, multivariate logistic regression of the 6 subpopulations revealed that the odds of LBP significantly increased with increasing HbA1c levels in normal weight diabetics. No other subpopulations reported significant relationships between LBP and HbA1c. LBP was also significantly associated with BMI for normal weight diabetics and also for obese subjects regardless of their DM status.Conclusions
LBP is significantly related to DM status, but this relationship is complex and may interact with BMI. These results support the concept that LBP may be improved in normal weight diabetic subjects with improved glycemic control and weight loss, and that all obese LBP subjects may benefit from improved weight loss alone. 相似文献88.
Familial risk and heritability of intellectual disability: a population-based cohort study in Sweden
89.
90.
Joseph F. Levy Rahul Khairnar Alexander V. Louie Timothy N. Showalter C. Daniel Mullins Mark V. Mishra 《Practical radiation oncology》2019,9(2):e172-e179